KENVUE INC (KVUE)

US49177J1025 - Common Stock

23.72  -0.1 (-0.42%)

After market: 23.82 +0.1 (+0.42%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

KENVUE INC

NYSE:KVUE (11/18/2024, 4:18:39 PM)

After market: 23.82 +0.1 (+0.42%)

23.72

-0.1 (-0.42%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month16.37%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap45.48B
Shares
PE19.93
Fwd PE18.97
Dividend Yield3.47%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

KVUE Daily chart

Company Profile

Kenvue, Inc. is a consumer health company. The company is headquartered in Skillman, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The firm operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The firm has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Company Info

KENVUE INC

199 Grandview Road

Skillman NEW JERSEY

P: 17325240400

Employees: 21780

Website: https://www.kenvue.com

KVUE News

ChartMill News Image10 hours ago - ChartmillIn-Depth Technical Analysis of KENVUE INC.

With a solid technical rating of 8 out of 10, KENVUE INC (NYSE:KVUE) is showing strong indications of a possible breakout.

News Image6 days ago - Market News VideoNotable Tuesday Option Activity: ZI, KVUE, ETR
News Image11 days ago - The Motley FoolKenvue (KVUE) Q3 2024 Earnings Call Transcript

KVUE earnings call for the period ending September 30, 2024.

News Image11 days ago - KenvueKenvue Reports Third Quarter 2024 Results
News Image18 days ago - KenvueNeutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
News Image19 days ago - The Motley FoolThis Big New Development Could Be Bullish for Kenvue Stock

Can tinkering around the edges actually make this stock more attractive?

KVUE Twits

Here you can normally see the latest stock twits on KVUE, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example